Rubicon Organics Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Rubicon Organics şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet

Jun 13

Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?

Jun 06

Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?

Jan 09

Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt

Sep 19

What Type Of Shareholders Own The Most Number of Rubicon Organics Inc. (CSE:ROMJ) Shares?

Jul 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: ROMJ şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: ROMJ şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Rubicon Organics Piyasaya Karşı Temettü Getirisi

ROMJ temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (ROMJ)	n/a
Pazarın Alt %25'i (CA)	1.8%
Pazarın En İyi %25'i (CA)	6.2%
Sektör Ortalaması (Pharmaceuticals)	2.4%
Analist tahmini (ROMJ) (3 yıla kadar)	n/a

Önemli Temettü: ROMJ şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, ROMJ şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: ROMJ şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: ROMJ herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Rubicon Organics Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.029 loss in 3Q 2023)

Rubicon Organics Inc. Provides Revenue Guidance for the Full Year 2024

Independent Director recently bought CA$52k worth of stock

Health Check: How Prudently Does Rubicon Organics (CVE:ROMJ) Use Debt?

Rubicon Organics Inc. Appoints Jesse McConnell to the Board of Directors

Second quarter 2024 earnings released: CA$0.008 loss per share (vs CA$0.002 loss in 2Q 2023)

Rubicon Organics Inc. to Report Q2, 2024 Results on Aug 15, 2024

Rubicon Organics Inc., Annual General Meeting, Jul 31, 2024

Rubicon Organics Inc. (CVE:ROMJ) Soars 27% But It's A Story Of Risk Vs Reward

Rubicon Organics Inc., Annual General Meeting, Jul 31, 2024

Consensus EPS estimates fall by 100%

First quarter 2024 earnings released: CA$0.033 loss per share (vs CA$0.01 loss in 1Q 2023)

Now 71% overvalued after recent price rise

Rubicon Organics Inc. Launches 1964 Supply Co. Full Spectrum Extracts (FSE) Vapes

Rubicon Organics Inc. to Report Q1, 2024 Results on May 15, 2024

Calculating The Fair Value Of Rubicon Organics Inc. (CVE:ROMJ)

Now 27% overvalued

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates have been downgraded.

New minor risk - Profitability

Rubicon Organics Inc. to Report Q4, 2023 Results on Mar 27, 2024

Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Rubicon Organics Inc. Appoints Janis Risbin as CFO

Third quarter 2023 earnings released: CA$0.029 loss per share (vs CA$0.036 profit in 3Q 2022)

Rubicon Organics Inc. Provides Earnings Guidance for the Year 2023

New minor risk - Share price stability

Rubicon Organics Inc. to Report Q3, 2023 Results on Nov 14, 2023

Rubicon Organics™ Launches Wildflower™ Edibles Crafted with CBD, CBN & CBG

High number of new directors

Is Rubicon Organics (CVE:ROMJ) A Risky Investment?

Rubicon Organics Inc. Announces Board Appointments

Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.022 loss in 2Q 2022)

Rubicon Organics Inc. Provides Earnings Guidance for the Year 2023

Rubicon Organics Inc. Announces New Product Launches Under Simply Bare Organic and 1964 Supply Co

Rubicon Organics Inc. to Report Q2, 2023 Results on Aug 16, 2023

Rubicon Organics Inc., Annual General Meeting, Sep 14, 2023

Benign Growth For Rubicon Organics Inc. (CVE:ROMJ) Underpins Stock's 26% Plummet

Is Rubicon Organics (CVE:ROMJ) Using Too Much Debt?

First quarter 2023 earnings released: CA$0.01 loss per share (vs CA$0.027 loss in 1Q 2022)

Rubicon Organics Inc. Provides Earnings Guidance for the Full Year 2023

Rubicon Organics Inc. to Report Q1, 2023 Results on May 23, 2023

Independent Director recently bought CA$64k worth of stock

Consensus EPS estimates increase from loss to CA$0.00 profit, revenue downgraded

Less than half of directors are independent

Insider recently sold CA$57k worth of stock

Would Rubicon Organics (CVE:ROMJ) Be Better Off With Less Debt?

Rubicon Organics Inc. Launches Eleven New Products in Quebec Under the Simply Bare™ Organic and 1964 Supply Co.™ Brands

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Insufficient new directors

Rubicon Organics Inc. Announces Resignation of Julie Lassonde as Board Member

Rubicon Organics Inc. to Report Q3, 2022 Results on Nov 14, 2022

Rubicon Organics Inc. Reiterates Earnings Guidance for the Year 2022

Here's Why Rubicon Organics (CVE:ROMJ) Can Afford Some Debt

Price target decreased to CA$2.75

Rubicon Organics Inc. Announces Resignation of Jesse McConnell as Chief Executive Officer, Effective December 31, 2022

Rubicon Organics Inc. Announces Resignation of Bryan Disher from the Board of Directors

Rubicon Organics Inc. to Report Q2, 2022 Results on Aug 15, 2022

Rubicon Organics Inc., Annual General Meeting, Sep 27, 2022

Rubicon Organics Inc. Announces Board Changes

Rubicon Organics Inc. to Report Q1, 2022 Results on May 24, 2022

Rubicon Organics Inc. Announces the Departure of Tim Roberts, Formerly President

Rubicon Organics Inc. to Report Q4, 2021 Results on Apr 18, 2022

Rubicon Organics Inc. to Report Q4, 2021 Results on Apr 14, 2022

Rubicon Organics Inc. Announces Launches Five New Strains

Rubicon Organics Launches New SKUs

Rubicon Organics Inc. Secures R&D License from Health Canada

Rubicon Organics Inc. Provides Revenues Guidance for the Year 2021

Rubicon Organics Inc. to Report Q4, 2020 Results on Apr 06, 2021

Rubicon Organics Enters into Extraction Services Agreement with The Valens Company

Rubicon Organics Inc. has completed a Composite Units Offering in the amount of CAD 20 million.

National Cannabis Distribution Enters into Exclusive Wholesale Distribution Agreement with Rubicon Organics in Saskatchewan

Rubicon Organics Inc. Receives Sales Amendment from Health Canada

Rubicon Organics Inc. Receives First Purchase Order from Quebec

Julie Lassonde to Join Rubicon Organics Board of Directors